» Articles » PMID: 39682356

The Effects of Different Treatments on Serum Trace Element Levels in Dogs with Heart Failure

Overview
Journal Animals (Basel)
Date 2024 Dec 17
PMID 39682356
Authors
Affiliations
Soon will be listed here.
Abstract

The prognostic and diagnostic role of some trace elements in heart diseases has been demonstrated. In this study, the effects of min. 30-day and min. 120-day treatment with pimobendan, enalapril, and furosemide, as monotherapy and in combination, on serum trace element levels in dogs with heart failure were evaluated. A total of 107 dogs were treated with pimobendan or enalapril as monotherapy and pimobendan + enalapril (PE), enalapril + furosemide (EF), or pimobendan + enalapril + furosemide (PEF) as combination therapy for a min. of 30 and 120 days. Serum copper (Cu), zinc (Zn), iron (Fe), cobalt (Co), magnesium (Mg), manganese (Mn), selenium (Se), and chromium (Cr) were measured by an inductive coupled plasma optical emission spectroscopy device. Mean serum Mg in dogs treated with pimobendan for a min. of 120 days was significantly lower than that for a min. of 30 days ( < 0.05). In dogs using the PEF combination, mean serum Fe was significantly higher in the min. 120-day treatment group than in the min. 30-day treatment group ( < 0.01). No significant difference was observed in mean serum Cu, Zn, Co, Mn, Se, or Cr between the treatment groups and the time periods ( > 0.05). The short- and long-term use of pimobendan, enalapril, furosemide, and their combinations may cause changes in mean serum Mg and Fe in dogs with heart failure.

References
1.
Mohr I, Weiss K . Current anti-copper therapies in management of Wilson disease. Ann Transl Med. 2019; 7(Suppl 2):S69. PMC: 6531644. DOI: 10.21037/atm.2019.02.48. View

2.
Elsherif L, Ortines R, Saari J, Kang Y . Congestive heart failure in copper-deficient mice. Exp Biol Med (Maywood). 2003; 228(7):811-7. DOI: 10.1177/15353702-0322807-06. View

3.
Tong G, Rude R . Magnesium deficiency in critical illness. J Intensive Care Med. 2005; 20(1):3-17. DOI: 10.1177/0885066604271539. View

4.
CHIPPERFIELD B, Chipperfield J . Differences in metal content of the heart muscle in death from ischemic heart disease. Am Heart J. 1978; 95(6):732-7. DOI: 10.1016/0002-8703(78)90503-3. View

5.
Khan A, Lubitz S, Sullivan L, Sun J, Levy D, Vasan R . Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2012; 127(1):33-8. PMC: 3541701. DOI: 10.1161/CIRCULATIONAHA.111.082511. View